Vical Incorporated - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VICL Nasdaq 2836 http://www.vical.com 1.41 0.00

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vical Incorporated

Why Vical (VICL) Might Be a Diamond in the Rough? - Mar 12th, 2014 5:10 am
Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference - Mar 5th, 2014 2:05 pm
Vical to Present at the 34th Annual Cowen Health Care Conference - Feb 26th, 2014 2:05 pm
VICAL INC Financials - Feb 20th, 2014 11:04 am
VICAL INC Files SEC form 10-K, Annual Report - Feb 14th, 2014 12:36 pm
Vical Q4 Loss Narrows - Feb 13th, 2014 9:10 am
Vical's CEO Discusses Q4 2013 Results - Earnings Call Transcript - Feb 12th, 2014 5:18 pm
Q4 2013 Vical Inc. Earnings Release - Before Market Open - Feb 12th, 2014 5:07 am
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - Feb 12th, 2014 4:30 am
Vical Reports 2013 Financial Results and Progress in Key Development Programs - Feb 12th, 2014 4:30 am
Vical to Present at the 2014 Leerink Global Healthcare Conference - Feb 7th, 2014 4:30 am
Vical Announces News Release and Conference Call Schedule for 2013 Financial Results - Feb 5th, 2014 4:30 am
What's Up With Vical? - Jan 15th, 2014 7:05 am
5 Stocks Poised for Breakouts - Jan 10th, 2014 11:20 am
VICAL INCORPORATED SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Vical Incorporated and Its Board of Directors and a Lead Plaintiff Deadline of December 31, 2013 -- VICL - Dec 24th, 2013 1:24 pm
Vical Initiates Trial Of Therapeutic HSV-2 Vaccine - Dec 17th, 2013 11:52 am
The Worst Biotech CEO of 2013 Is... - Dec 17th, 2013 5:58 am
Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes - Dec 17th, 2013 5:31 am
Vical Announces Initiation of Phase 1/2 Trial of a Therapeutic HSV-2 Vaccine for Genital Herpes - Dec 17th, 2013 5:00 am
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Vical Incorporated - Dec 13th, 2013 7:32 pm